Disease progression among patients who receive available bladder preservation therapies after failure of BCG therapy in the SEER-Medicare data. Proposal of a new subcategory of the pT3 classification: ...
Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma. Impact of tumor burden on treatment patterns and outcomes in patients with locally advanced or metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results